Additionally, if successful, HISTORI may pave the way for long-term, large-scale GLP-1 agonist interventions in schizophrenic patients with pre-diabetes, aiming to reduce the number of hardcore clinical cardiovascular endpoints, and thereby prolonging their life expectancy. Here, GCG is linked to diabetes mellitus.